Oncodesign and Hitgen have initiated a worldwide strategic alliance in Integrated Drug Discovery Services for the identification and progression of new chemical entities, spanning from Hit finding up to preparation of the Investigational New Drug filing.   “We are extremely delighted to engage with HitGen, a highly recognized and world leader in DNA-encoded libraries, into this strategic partnership,” said Fabrice Viviani, senior executive vice-president and chief of Oncodesign Services. “...